スポンサーリンク
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Japan | 論文
- Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Proteins Interacting With the Third Cytoplasmic Loop of Dopamine D2 and D3 Receptors
- Transcriptional Regulation of Neuronal Genes and Its Effect on Neural Functions : Expression and Function of Forkhead Transcription Factors in Neurons
- Akt Is a Molecular Target for Signal Transduction Therapy in Brain Ischemic Insult
- Functional Proteins Involved in Regulation of Intracellular Ca^ for Drug Development : Role of Calcium/Calmodulin-Dependent Protein Kinases in Ischemic Neuronal Death
- Inhibition of Nitric Oxide Production and Protein Tyrosine Nitration Contribute to Neuroprotection by a Novel Calmodulin Antagonist, DY-9760e, in the Rat Microsphere Embolism(Pharmacology)
- The Post-ischemic Administration of 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Calmodulin Antagonist, Prevents Delayed Neuronal Death in Gerbil H
- Characterization of αT3-1 Cells Stably Transfected with Luteininzing Hormone β-Subunit Complementary Deoxyribonucleic Acid
- Cytoprotective Effect of 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e) Against Ischemia/Reperfusion-Induced Injury in Rat Heart Involves Inhibition of Fodrin
- Spatiotemporal expression of four isoforms of Ca^/calmodulin-dependent protein kinase I in brain and its possible roles in hippocampal dendritic growth
- Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders : Proteins Interacting With the Third Cytoplasmic Loop of Dopamine D_2 and D_3 Receptors
- The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation
- Crucial Interactions Between Selective Serotonin Uptake Inhibitors and Sigma-1 Receptor in Heart Failure